News
Already the 6th Cyclone® KIUBE Rigging in China this year!
The Cyclone® KIUBE has been placed into its final position at HIC in Changshu, China. The new radiopharmacy will produce […]
See moreInstallation of the Cyclone® 70 at IBS
After one week of rigging, the installation of the Cyclone® 70P for the Institute of Basic Science (IBS) has now […]
See moreIBA and NorthStar Medical Radioisotopes Sign Contract for Rhodotron® Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)
Louvain-La-Neuve, Belgium, and BELOIT, Wis., USA November 18, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in […]
See moreIBA BUSINESS UPDATE – THIRD QUARTER 2021
Louvain-La-Neuve, Belgium, November 18, 2021 –IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces […]
See moreThe clinical value PET myocardial blood flow quantification and practical aspects of implementing a Cardiac PET Program
The clinical value of myocardial flow quantification is supported by numerous observational and clinical studies in various populations. Its use […]
See moreRigging of the Cyclone® 70 at the Institute of Basic Science in Korea
When a 140 tons cyclotron has to be placed into its vault, it is always impressive ! It requires precision […]
See moreAcceptance of the Cyclone® KIUBE and Synthera®+ in Fushan, China
Junqi Pharmaceutical Tech Co., LTD will now be able to start their F-18 production with State of the Art equipment’s; […]
See moreFirst Cyclone® KIUBE self-shielded acceptance in China!
The Cyclone KIUBE at HTA Beijing site passed the acceptance test! The new radiopharmacy will now produce F-18 for in-house […]
See moreSecuring Gallium-68 availability with liquid target production on mid-energy cyclotrons: Users' experience and scaling up
Don’t miss the e-poster presentation at EANM : “Securing Gallium-68 availability with liquid target production on mid-energy cyclotrons: Users' experience and […]
See more